About R. Carruthers
R. Carruthers is a director at OnKure Therapeutics.
Form D filings name R. Carruthers as a director at OnKure.
R. Carruthers reports to the SEC as a director or officer of 5 public companies, including Edgewise Therapeutics (EWTX), Elevation Oncology (ELEV) and Fresh Tracks Therapeutics (FRTX).
R. Carruthers first appears on SEC filings in 2015.
Experience
This experience comes from SEC filings. The years are when the filings name R. Carruthers in the role, so the role may have started earlier or lasted longer.
OI
OnKure Therapeutics, Inc.
Director
2024 – 2026 · Public company (OKUR)
EI
Edgewise Therapeutics, Inc.
Chief Financial Officer
2021 – 2025 · Public company (EWTX)
EI
Elevation Oncology, Inc.
Director
2021 – 2025 · Public company (ELEV)
FI
Fresh Tracks Therapeutics, Inc.
Chief Financial Officer
2019 – 2020 · Public company (FRTX)
AI
Alpine Immune Sciences, Inc.
Interim President / CFO
2015 – 2017 · Public company (ALPN)
Key Colleagues at Startups
The people R. Carruthers works with at each company, as listed on that company's latest Form D.
OnKure, Inc. · Form D, Apr 3, 2023
AP
Anthony Piscopio
Executive officer and director
AP
Andrew Phillips
Director
IM
Isaac Manke
Director
NS
Nicholas Saccomano
Director
DW
Duncan Walker
Executive officer
JW
James Winkler
Executive officer
JL
Jason Leverone
Executive officer
KO
Keith Olivia
Secretary